Hai Wang

发表

Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia

Kai Chen, C. Long, Xiurong Qin, 2008, Journal of hypertension.

Effect of Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Agonist, on Ischemia-Reperfusion Injury in Rats

Kai Chen, C. Long, Hai Wang, 2007, Pharmacology.

Hypoxic pulmonary hypertension (HPH) and iptakalim, a novel ATP-sensitive potassium channel opener targeting smaller arteries in hypertension.

Hai Wang, Yuan Tang, Ying-li Zhang, 2006, Cardiovascular drug reviews.

Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients

Rui-feng Duan, W. Cui, Hai Wang, 2011, Acta Pharmacologica Sinica.

Mutational analysis of the Kir6.1 gene in Chinese hypertensive patients treated with the novel ATP-sensitive potassium channel opener iptakalim.

Rui-feng Duan, W. Cui, Hai Wang, 2011, Experimental and therapeutic medicine.

Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy

C. Long, Yan-fang Zhang, W. Cui, 2014, International journal of molecular medicine.

The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function

C. Long, Zhi-yuan Pan, W. Cui, 2011, Acta Pharmacologica Sinica.

Stimulation of non-neuronal muscarinic receptors enhances chemerin/ChemR23 system in dysfunctional endothelial cells.

C. Long, Zhi-yuan Pan, Yan-fang Zhang, 2013, Life sciences.

A New ATP-Sensitive Potassium Channel Opener Reduces Blood Pressure and Reverses Cardiovascular Remodeling in Experimental Hypertension

C. Long, Hai Wang, Ying-li Zhang, 2005, Journal of Pharmacology and Experimental Therapeutics.

K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.

C. Long, Hai Wang, Ru-huan Wang, 2009, Cardiovascular research.

Activation of SUR2B/Kir6.1 Subtype of Adenosine Triphosphate-sensitive Potassium Channel Improves Pressure Overload-induced Cardiac Remodeling via Protecting Endothelial Function

C. Long, W. Cui, Hai Wang, 2010, Journal of cardiovascular pharmacology.

The new antihypertensive drug iptakalim activates ATP-sensitive potassium channels in the endothelium of resistance blood vessels

W. Cui, Hai Wang, Su-yang Wang, 2015, Acta Pharmacologica Sinica.

Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells

C. Long, Yan-fang Zhang, W. Cui, 2016, Acta Pharmacologica Sinica.

ATP-sensitive potassium channel openers and 2,3-dimethyl-2-butylamine derivatives.

C. Long, Hai Wang, Lin Wang, 2007, Current medicinal chemistry.

Bioavailability, tissue distribution, and excretion characteristics of the novel carbonic anhydrase inhibitor tolsultazolamide in rats

Zhi-yuan Pan, Yan-fang Zhang, W. Cui, 2013, Acta Pharmacologica Sinica.

Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis

W. Cui, Hai Wang, Chun-gang Li, 2016, Acta Pharmacologica Sinica.

Iptakalim Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

C. Long, W. Cui, Hai Wang, 2013, Journal of cardiovascular pharmacology and therapeutics.

Natakalim Ameliorates Isoproterenol-Induced Chronic Heart Failure by Protecting against Endothelial Dysfunction

Yanfang Zhang, C. Long, W. Cui, 2016, Pharmacology.

Targeting Ischemic Stroke with a Novel Opener of ATP-Sensitive Potassium Channels in the Brain

G. Hu, Xing-chun Tang, Hai Wang, 2004, Molecular Pharmacology.

Brain protection against ischemic stroke using choline as a new molecular bypass treatment

C. Long, Hai Wang, Ru-huan Wang, 2015, Acta Pharmacologica Sinica.

SUR2B/Kir6.1 channel openers correct endothelial dysfunction in chronic heart failure via the miR-1-3p/ET-1 pathway.

C. Long, Yan-fang Zhang, Hai Wang, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Targeting Hypertension With a New Adenosine Triphosphate–sensitive Potassium Channel Opener Iptakalim

Yanfang Zhang, C. Long, Zhi-yuan Pan, 2010, Journal of cardiovascular pharmacology.

Targeting Cholinesterase Inhibitor Poisoning with a Novel Blocker Against Both Nicotinic and Muscarinic Receptors

W. Cui, Hai Wang, Wang-qian Luo, 2010, Neurotoxicity Research.

Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta

C. Long, Hai Wang, Hua-mei He, 2005, Acta Pharmacologica Sinica.

A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells.

C. Shi, C. Long, Hai Wang, 2007, Cardiovascular research.

Proteomics reveals potential non-neuronal cholinergic receptor-effectors in endothelial cells

W. Shen, C. Long, Zhi-yuan Pan, 2014, Acta Pharmacologica Sinica.

The molecular pathway of ATP-sensitive potassium channel in endothelial cells for mediating arteriole relaxation.

Yanfang Zhang, C. Long, Zhi-yuan Pan, 2015, Life sciences.

An improved inverse PCR protocol for the generation of T-vectors.

Yanfang Zhang, C. Long, W. Cui, 2015, Acta biochimica et biophysica Sinica.

Targeting small arteries of hypertensive status with novel ATP-sensitive potassium channel openers.

Hai Wang, Ying-li Zhang, Yu-Ping Chen, 2005, Current vascular pharmacology.